To encapsulate, the potent symbiosis between glucocorticoids and RANKL energizes the SYK/SHP2/NF-κB pathway, endorsing bone marrow monocyte differentiation into osteoclasts and precipitating the advance of osteoporosis. Here, PTPN11 is linked to osteoporosis.